Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary.
第一作者:
M B,Hannouf
第一单位:
Department of Epidemiology and Biostatistics. Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
作者:
医学主题词
预算(Budgets);费用效益分析(Cost-Benefit Analysis);决策支持技术(Decision Support Techniques);决策树(Decision Trees);基因表达谱(Gene Expression Profiling);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);疾病遗传易感性(Genetic Predisposition to Disease);卫生保健费用(Health Care Costs);人类(Humans);马尼托巴(Manitoba);Markov链(Markov Chains);模型, 经济学(Models, Economic);肿瘤, 未知原发灶(Neoplasms, Unknown Primary);表型(Phenotype);试验预期值(Predictive Value of Tests);预后(Prognosis);质量校正寿命(Quality-Adjusted Life Years);登记(Registries);时间因素(Time Factors)
DOI
10.1038/tpj.2015.94
PMID
27019982
发布时间
2018-11-13
- 浏览23
The pharmacogenomics journal
286-300页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



